#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pulmonary arterial hypertension Systemic mastocytosis Ichthyosis Acute graft versus host disease in skin Epilepsy Infection in an immunocompromised host Ewing's sarcoma Congenital disorder of glycosylation Immune-mediated renal disorder Primary immunodeficiency syndrome Anal cancer recurrent Neuroendocrine cell hyperplasia of infancy Conjunctivitis allergic Ornithine transcarbamoylase deficiency Cystic fibrosis respiratory infection suppression More trials…

    Learn about Rare Diseases

    Gastrointestinal stromal tumour – Diagnostics Leiomyosarcoma metastatic – Basic Information Isodicentric chromosome 15 syndrome – Treatment Acute respiratory distress syndrome – Life with Disease Osteosarcoma recurrent – Life with Disease Encephalitis autoimmune – Life with Disease Haemophilia B with anti factor IX – Treatment Mucopolysaccharidosis II – Diagnostics Amyotrophic lateral sclerosis – Basic Information Hairy cell leukaemia recurrent – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Bendamustine Hydrochloride Simeticone Dextromethorphan Hydrobromide Gr0015 Galcanezumab Rmc-035 TORASEMIDE Ibuprofen Brexpiprazole Afm24 Enmetazobactam Magnesium Stearate Gen1046 DESMOPRESSIN ACETATE Tuparstobart AAV9-CTNT-COBAG3 Sevoflurane Inupadenant Hydrochloride Prax-628 Follitropin Delta More therapies…

    Learn about Your Condition

    Influenza Device related infection Hyperparathyroidism primary Autoimmune haemolytic anaemia Ventricular tachycardia Epstein-Barr virus infection Aplasia pure red cell Infection Retinopathy of prematurity Polymyositis Anorexia nervosa Critical illness Pericarditis Vulval cancer recurrent Cold urticaria More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Immune system processes

  • Study on Deucrictibant and Icatibant for Treating Hereditary Angioedema Attacks in Adolescents and Adults

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Icatibant
    • Deucrictibant
    Austria Bulgaria Czechia France Germany Hungary +8

  • Study Comparing Tacrolimus Formulations for Preventing Kidney Transplant Rejection in Adults

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Tacrolimus
    Germany

  • Safety Study of Efgartigimod in Adults with Primary Sjögren’s Syndrome

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Sjogren’s syndrome
    Investigated Drugs:
    • Efgartigimod Alfa
    Belgium Hungary Poland

  • Study on Tegoprubart for Preventing Kidney Transplant Rejection in Patients

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Kidney transplant rejection
    Investigated Drugs:
    • Antithymocyte Immunoglobulin
    • At-1501
    • Tegoprubart
    France Germany Spain

  • Study on the Effects of Upadacitinib in Adults with Moderate to Severe Systemic Lupus Erythematosus (SLE)

    Not recruiting

    3 1
    Investigated Drugs:
    • Upadacitinib
    Belgium Bulgaria Croatia Estonia France Germany +10

  • Study of GLPG3667 for Adults with Active Systemic Lupus Erythematosus

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Systemic lupus erythematosus
    Investigated Drugs:
    • Glpg3667 Fumarate
    Bulgaria France Germany Hungary Poland Spain
Previous Page
1 … 11 12 13 14 15
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!